Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (4)
  • 2025 (34)
  • 2024 (39)
  • 2023 (64)
  • 2022 (95)
  • 2021 (73)
  • 2020 (11)
  • 2019 (7)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Diversion Division (253)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • HIDTA (104)

Drug Name

  • Fentanyl (81)
  • Oxycodone (49)
  • Opioids (45)
  • Cocaine (38)
  • Heroin (28)
  • Methamphetamine (24)
  • Hydromorphone (15)
  • Synthetic Opioids (14)
  • Morphine (8)
  • Benzodiazepines (7)
  • Marijuana (Cannabis) (6)
  • Amphetamines (3)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • GHB (1)

Field Division

  • Washington, DC (44)
  • New Jersey (38)
  • St. Louis (32)
  • New England (31)
  • Chicago (26)
  • New York (22)
  • Seattle (22)
  • Miami (21)
  • Atlanta (13)
  • El Paso (12)
  • Dallas (10)
  • Sede (10)
  • Houston (8)
  • San Francisco (8)
  • Los Angeles (7)
  • Louisville (5)
  • Rocky Mountain (5)
  • San Diego (5)
  • New Orleans (4)
  • Omaha (4)
  • Phoenix (3)
  • Philadelphia (1)
Clear All Results
331 Results - Showing 191 to 200
PRESS RELEASE

Consent Decree Approved Between the United States and Baltimore-Based Pharmacy and Pharmacist Alleged to Have Illegally Dispensed Controlled Substances

Baltimore, Md. - U.S. District Judge Richard D. Bennett approved the United States’ consent decree with Ketan K. Dankhara, a Baltimore-based pharmacist, and Falls RX, LLC d/b/a Ultra Care Pharmacy Baltimore (“Ultra Care”), resolving the United States’ civil allegations that Dankhara and Ultra Care violated the Controlled Substances Act (“CSA”)...
PRESS RELEASE

Newark Man Sentenced to 10 Years in Prison for Role in Drug Trafficking Organization

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Newark man was sentenced today to 120 months in prison for his role in a drug trafficking conspiracy...
PRESS RELEASE

Two Lebanese Citizens Extradited from Republic of Georgia to Face International Money Laundering Charges

Brooklyn, N.Y. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the Eastern District of New York Breon Peace announced two citizens of Lebanon, Mohamad Yassine and Hassan Rahman, will be arraigned today on money laundering charges for operating...
PRESS RELEASE

DEA Chicago Suspends Registration of Suburban Chicago Pharmacy

CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on April 27, 2022, DEA Chicago Diversion Investigators delivered an Immediate Suspension Order to Evergreen Park Pharmacy, located at 2850 W. 95th Street, Suite 100, Evergreen Park, Illinois, suspending its DEA...
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...
PRESS RELEASE

Roanoke Woman Sentenced to Five Years in Prison for Dealing Heroin

ROANOKE, Va. – A Roanoke woman, who sold drugs on behalf of her incarcerated boyfriend, was sentenced today to 60 months in federal prison. Aminee Jewell Davenport, 35, pleaded guilty in November 2021 to one count of distributing more than 100 grams of heroin. According to court documents, Davenport was...
PRESS RELEASE

Ulster County Dentist Pleads Guilty to Fraudulently Acquiring and Obtaining Oxycodone

ALBANY, N.Y. – Vivian Letizia, age 63, of Stone Ridge, New York, pled guilty today to acquiring and obtaining a controlled substance by misrepresentation, fraud, deception, or subterfuge. The announcement was made by United States Attorney Carla B. Freedman and Timothy Foley, Acting Special Agent in Charge of the U.S...
PRESS RELEASE

Atlantic County Man Admits Role in Drug Distribution Scheme

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced that an Atlantic County, New Jersey, man today admitted his role in a drug distribution scheme. Ricardo Clavijo, 40...
PRESS RELEASE

Fairbanks Man Sentenced to 14 Years in Prison

FAIRBANKS, Alaska – A Fairbanks man was sentenced to 14 years in prison followed by eight years of supervised release for distributing counterfeit pills containing fentanyl resulting in the death of another individual. In issuing the sentence, U.S. District Judge Ralph R. Beistline noted that the 21-year-old victim had his...
PRESS RELEASE

Las Cruces psychiatrist pleads guilty to unlawfully prescribing opioids

ALBUQUERQUE, N.M. – Mark Beale, 75, of Las Cruces, New Mexico, pleaded guilty on March 25 in federal court to unlawful dispensing and distributing of a schedule II controlled substance. Beale will remain on conditions of release pending sentencing. A federal grand jury indicted Beale on June 23, 2021. According...

Paginación

  • Primera página «
  • Anterior
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Current page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster